Mindray Medical International (MR) Reports In-Line Q1 EPS of 34c

Mindray Medical International (NYSE: MR) reported Q1 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $219 million versus the consensus estimate of $217.49 million.

Mindray Medical International reaffirmed FY2012 guidance.

For earnings history and earnings-related data on Mindray Medical International (MR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• SeaStar Medical (ICU) Misses Q1 EPS by 4c
• Epsilon Energy Ltd. (EPSN) Reports Q2 EPS of $0.23